Stephen H. Barnes, Chief Financial Officer of Accolade, Inc. (NASDAQ:ACCD), has reported the sale of 228 shares of common stock, valued at approximately $859. The shares were sold at an average price of $3.771 per share on October 11, 2024. This transaction was carried out to cover tax withholding obligations related to the vesting of Restricted Stock Units (RSUs), as noted in the filing. Following the sale, Barnes retains direct ownership of 203,048 shares.
Additionally, Barnes converted 770 RSUs into common stock on October 10, 2024. This conversion did not involve any cash transaction. The RSUs, which vest over a period of three years, are a part of Barnes' compensation package, providing him the right to receive shares of Accolade's common stock.
In other recent news, Accolade Inc. reported strong second-quarter results for 2025, with revenues reaching $106.4 million and surpassing its adjusted EBITDA guidance. The healthcare solutions provider also confirmed its fiscal year 2025 revenue guidance between $460 million to $475 million and projected a positive adjusted EBITDA of $15 million to $20 million. Amid these developments, several analyst firms revised their price targets for Accolade. Wells Fargo revised the price target downwards to $6.00 due to concerns over delayed deal closures potentially affecting the company's anticipated growth. Similarly, Stephens, Canaccord Genuity, Truist Securities, and BofA Securities also adjusted their price targets while maintaining positive ratings on the stock. Despite the anticipated slower revenue growth in fiscal year 2026 due to staggered launches, these firms expressed confidence in Accolade's ability to secure new business and meet performance guarantees. These recent developments highlight the evolving dynamics of Accolade's financial performance and strategic direction.
InvestingPro Insights
To provide additional context to Stephen H. Barnes' recent stock transactions, let's examine some key financial metrics and insights from InvestingPro for Accolade, Inc. (NASDAQ:ACCD).
As of the latest data, Accolade's market capitalization stands at $301.21 million, reflecting the company's current valuation in the market. The stock's performance has been challenging, with a significant 57.23% decline over the past six months. This downward trend aligns with an InvestingPro Tip noting that the stock has taken a big hit over the last six months.
Despite the recent stock performance, Accolade's revenue growth remains positive. The company reported revenue of $441.03 million for the last twelve months as of Q2 2025, with a revenue growth rate of 16.04% over the same period. This growth suggests that the company continues to expand its business operations despite market challenges.
An important InvestingPro Tip highlights that Accolade operates with a moderate level of debt, which could provide some financial flexibility as the company navigates its growth strategy. Additionally, the company's liquid assets exceed short-term obligations, indicating a relatively stable short-term financial position.
It's worth noting that InvestingPro offers 10 additional tips for Accolade, providing investors with a more comprehensive analysis of the company's financial health and market position. These insights can be particularly valuable when considering the context of executive stock transactions and overall company performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.